Early salvage radiotherapy (eSRT) represents the only curative option for prostate cancer patients experiencing biochemical recurrence (BCR) for local recurrence after radical prostatectomy (RP).
Briganti, A., Karnes, R. J., Joniau, S., Boorjian, S. A., Cozzarini, C., Gandaglia, G., Hinkelbein, W., Haustermans, K., Tombal, B., Shariat, S., Sun, M., Karakiewicz, P. I., Montorsi, F., Van Poppel, H., & Wiegel, T. (2014). Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy. European Urology, 66(3), 479-486. https://doi.org/10.1016/j.eururo.2013.11.045 (Original work published 2014)